Explore News By Topic

03/14/2024

The Prostate Cancer Foundation Announces 2023 Challenge Awards Totaling More Than $21 Million For Prostate Cancer Research

LOS ANGELES, Calif., March 14, 2024 – The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research. PCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly... Read More

03/05/2024

UroToday and PRIMR Announce Strategic Partnership to Enhance Clinical Trial Awareness

Digital Science Press / UroToday RENO, Nev., March 5, 2024 /PRNewswire/ -- UroToday, the premier global hub for urology news and education, and PRIMR, a pioneering oncology clinical trial patient education company, proudly announce their inaugural strategic partnership. This groundbreaking collaboration is set to redefine clinical trial awareness and education, marking a... Read More

02/22/2024

The Prostate Cancer Foundation and the American Cancer Society Announce First ACS-PCF Young Investigator Award

LOS ANGELES, Calif., February 22, 2024 – The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care... Read More

01/11/2024

New Prostate Cancer Foundation-Funded Research To Speed Up Prostate Cancer Clinical Trials Worldwide

LOS ANGELES, Calif., January 11, 2024 -- New analysis of data published by Susan Halabi, PhD, of Duke University, USA could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard. The study published online January 5, 2024, in the Journal of Clinical Oncology, reviewed... Read More

12/05/2023

The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Health Equity Research Challenge Awards

LOS ANGELES, Calif., November 30, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced three 2023 Bayer-PCF Health Equity Research Challenge Awards totaling $600,000. The awards will support novel health equity research projects with the goal of reducing racial and ethnic disparities in the diagnosis and treatment of... Read More

11/17/2023

Breaking News: FDA Approves Enzalutamide as a Treatment Option for Patients with Recurrent Prostate Cancer at High Risk of Metastases

Patients who have been treated for localized prostate cancer and are now seeing their PSA rise rapidly are at high risk of metastasis and of death from prostate cancer. Now, patients and their doctors have a new treatment option that decreases these risks. The FDA has approved enzalutamide alone OR... Read More

11/17/2023

Pfizer and Astellas’ XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting

XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer TOKYO and NEW YORK, November 16, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) today... Read More

10/25/2023

The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Darolutamide Challenge Awards

LOS ANGELES, Calif., October 25, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced two 2023 Bayer-PCF Darolutamide Challenge Awards totaling $2 million to support clinical investigations on darolutamide in prostate cancer. In 2019, the U.S. Food and Drug Administration approved Bayer’s Nubeqa® (darolutamide), an androgen receptor inhibitor... Read More

10/04/2023

Washington Commanders announce month-long programming promoting early detection and celebrating survivors and those currently undergoing treatment as part of NFL’s ‘Crucial Catch’ campaign

LANDOVER, Md., October 4, 2023 – Throughout the month of October, the Washington Commanders will host events dedicated to health equity and promoting early detection best practices as part of the NFL's Annual Crucial Catch initiative. To headline the month, the team will host its Crucial Catch-themed game under the... Read More

08/31/2023

The Prostate Cancer Foundation Challenges America To Get Healthy This September

LOS ANGELES, Calif., August 31, 2023 – September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining two Prostate Cancer Awareness Challenges: 108 Miles in September Run/Walk Challenge and 30 Foods in 30 Days Healthy Eating Challenge.... Read More